Trial Profile
METRONOMIC CHEMOTHERAPY WITH URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE (CTX) AND CELECOXIB IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES: A PILOT CLINICAL STUDY WITH PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATIONS.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Cyclophosphamide (Primary) ; Tegafur/uracil (Primary)
- Indications Colorectal cancer; Gastric cancer; Liver cancer; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms COMET-GI
- 08 Jul 2011 New trial record